Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Davidson College

Drug Discovery and Lead Optimization

Davidson College via edX Professional Certificate

Overview

Embark on a journey through the fascinating world of pharmaceutical research with this comprehensive six-course program. The Professional Certificate in Drug Discovery and Lead Optimization provides you with a complete view of how potential new medicines are discovered and advanced into clinical trials. This program stands at the intersection of science, business, and regulation—equipping you with the multidisciplinary knowledge that defines successful pharmaceutical professionals.

Whether you're looking to enter the pharmaceutical industry, enhance your current role, or deepen your understanding of drug development, this certificate program delivers critical insights into the complex process of bringing new treatments to patients. Through real-world case studies and practical applications, you'll develop a sophisticated understanding of how scientific innovation translates into life-changing therapies.

No prior experience is required to begin this transformative learning journey, making it accessible to career-changers and industry professionals alike. The program's modular approach allows you to build your expertise systematically, from foundational concepts to advanced techniques in lead optimization.

Syllabus

Courses under this program:
Course 1: Innovate & Regulate: Drug Research, Costs, Clinical Trials & Approval

At some point in their life, essentially everyone needs to use medication for some type of disease treatment or cure. While medications offer great benefits, the cost of drugs, especially new drugs, and the lack of treatment for some diseases can raise questions about business activity behind the creation of new drugs. Better understanding of how drugs are discovered and developed as well as the legal and regulatory factors that affect the industry can help one better recognize both the shortcomings and opportunities faced by the drug industry at large.



Course 2: Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes

Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.



Course 3: Introduction to Pharmacokinetics: From ADME to PK/PD

A critical aspect of a drug involves how a drug is dosed and circulates throughout the body of a patient. These qualities are aspects of a drug’s pharmacokinetics or PK. Pharmacokinetics encompasses how a drug is absorbed and flows through a patient until it is ultimately eliminated. While pharmacokinetics covers drug behavior in a living organism, PK properties can often be predicted through laboratory tests for a compound’s ADME properties. ADME stands for absorption, distribution, metabolism, and excretion. The PK and ADME properties of potential drug are closely monitored throughout the discovery and early development stages of a drug campaign.



Course 4: Preclinical Safety: From In Vitro Assays to Human Dose Predictions

Drugs are approved based on their “safety and efficacy”. Determining the safety of a drug occurs through studies that are largely completely separate from efficacy studies. The safety studies fall under the umbrella of preclinical safety. While a drug’s therapeutic benefit is typically narrow and well-defined, the potential safety risks of a compound can be very broad. Preclinical studies therefore search broadly in order to reveal any possible safety issues in a compound. Safety studies ultimately determine dosing limits for clinical trials as well as the final approved drug product.



Course 5: Lead Discovery & Optimization for Efficacy, PK, & Safety

Understanding the efficacy, potency, pharmacokinetics, and safety of compounds is important, but compounds almost always require improvement in their properties in order to become drugs. The process of improvement is called lead optimization and requires a thorough understanding of how a molecule’s structure affects its function, whether efficacy, PK, or toxicity. Unraveling a compound’s structure-function relationship enables lead optimization and hopefully results in the discovery of a compound that can be advanced into clinical trials.



Course 6: Literature Case Studies in Drug Discovery

Once a person understands the ideas of drug efficacy, potency, pharmacokinetics, and safety, original research articles can be readily understood. The Journal of Medicinal Chemistry of the American Chemical Society regularly publishes a series of articles called Drug Annotations. These articles summaries a drug discovery program from a pharmaceutical company. The article covers everything from the indication of the drug, key pathways and promising drug targets within the pathways, library screening, lead selection, lead optimization, and both preclinical safety and PK/ADME studies. The articles are excellent articles for students who are testing their knowledge of drug discovery.



Courses

Taught by

Erland Stevens

Reviews

Start your review of Drug Discovery and Lead Optimization

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.